Shopping Cart 0
Cart Subtotal
USD 0

Virbac Group (VIRP)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Virbac Group (VIRP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Virbac Group (Virbac) is an animal health company, which specializes in the development and production of vaccines and medicines for domestic animals and livestock. It manufactures pet medications such as vaccines, antibiotics, pest control drugs, mouth/dental care products, anesthetics, anti-inflammatory drugs and dermatological products for horses, dogs, cats and livestock. Virbac products include ear cleanser for dogs and cats; a food supplement for cattle; tablets for the prevention of canine heartworm disease and treatment of roundworms and hookworms; general anesthetics and others. The company has manufacturing, research and development, and operational subsidiaries across Europe, North America, Asia-Pacific, Latin America, Africa and the Middle East. Virbac is headquartered in Carros, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Virbac Group-Key Facts 5

Virbac Group-Key Employees 6

Virbac Group-Key Employee Biographies 7

Virbac Group-Major Products and Services 8

Virbac Group-History 9

Virbac Group-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 14

Virbac Group-Business Description 14

Virbac Group-Corporate Strategy 15

Virbac Group-SWOT Analysis 16

SWOT Analysis-Overview 16

Virbac Group-Strengths 16

Virbac Group-Weaknesses 17

Virbac Group-Opportunities 18

Virbac Group-Threats 19

Virbac Group-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Virbac Group, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

Virbac Group, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

Virbac Group, Recent Deals Summary 30

Section 5-Appendix 31

Methodology 31

Ratio Definitions 31

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Virbac Group, Performance Chart (2012-2016) 25

Virbac Group, Ratio Charts 27

Virbac Group, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

Virbac Group, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29


List Of Table

List of Tables

Virbac Group, Key Facts 5

Virbac Group, Key Employees 6

Virbac Group, Key Employee Biographies 7

Virbac Group, Major Products and Services 8

Virbac Group, History 9

Virbac Group, Subsidiaries 11

Virbac Group, Key Competitors 20

Virbac Group, Ratios based on current share price 21

Virbac Group, Annual Ratios 22

Virbac Group, Annual Ratios (Cont...1) 23

Virbac Group, Annual Ratios (Cont...2) 24

Virbac Group, Interim Ratios 26

Virbac Group, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

Virbac Group, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

Virbac Group, Recent Deals Summary 30

Currency Codes 31

Capital Market Ratios 31

Equity Ratios 32

Profitability Ratios 32

Cost Ratios 33

Liquidity Ratios 33

Leverage Ratios 34

Efficiency Ratios 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com